Carbon Monoxide as a Potential Therapeutic Agent: A Molecular Analysis of Its Safety Profiles

S Bansal, D Liu, Q Mao, N Bauer… - Journal of Medicinal …, 2024 - ACS Publications
Carbon monoxide (CO) is endogenously produced in mammals, with blood concentrations
in the high micromolar range in the hemoglobin-bound form. Further, CO has shown …

Low-dose carbon monoxide is neuroprotective in rodent models of Parkinson's disease

KN Rose, M Zorlu, X Xue, W Cai, S Lin… - bioRxiv, 2023 - biorxiv.org
Carbon monoxide (CO) has emerged as a potential neuroprotective agent that could
underlie the reduced risk of Parkinson's disease (PD) among smokers. Here, we evaluated …